ULTRAGENYX PHARMACEUTICAL INC. (RARE) Gross margin 2017–2018
ULTRAGENYX PHARMACEUTICAL INC. (RARE) gross margin by fiscal year — reported gross profit divided by reported revenue.
97.8%FY2018 · since FY2017: 100.0% → 97.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | 97.8% | -2.2 pp |
| FY2017 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RARE financial trends
RARE RevenueRARE Net incomeRARE Net marginRARE Gross profitRARE Operating incomeRARE Operating marginRARE Operating cash flowRARE Free cash flowRARE Capital expendituresRARE Return on equityRARE Stock buybacksRARE Dividends paidRARE Total assetsRARE Total liabilitiesRARE Shareholders’ equityRARE overview →